CTRI/2024/05/068041尚未招募Unknown
Reliability of longterm preservation of immunofluorescence slides: a prospective observational study - NI
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •All DIF positive slides that is reported in the DIF lab.
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
A long-term, open follow-up of the immunogenicity and safety of GlaxoSmithKline Biologicals’ HPV-16/18 VLP/AS04 vaccine in healthy female subjects up to 10 years after administration of the first vaccine dose in study HPV-013. - HPV-025 EXT 013For the prevention of high-grade cervical intraepithelial neoplasia (CIN grades 2 and 3) and cervical cancer causally related to human papillomavirus (HPV) types 16 and 18.EUCTR2008-000369-44-DEGlaxoSmithKline Biologicals600
已完成
3 期
Durability of Immunogenicity and Effectiveness of the heterologous COVID-19 vaccination in kidney transplant recipientsImmunogenicity of the vaccineEffectiveness of the vaccinehumoral immunity, cell-mediated immunity, SARS-CoV-2, immunization, immunocompromisedTCTR20220511002ational Council Researach of Thailand100
进行中（未招募）
不适用
Follow-up study to evaluate the long-term immunogenicity and safety ofGlaxoSmithKline Biologicals' HPV (580299) vaccine in healthy femalesubjects.EUCTR2009-011357-41-DEGlaxoSmithKline Biologicals667
进行中（未招募）
不适用
A long-term, open, follow-up of the immunogenicity and safety of GlaxoSmithKline Biologicals’ HPV-16/18 L1 VLP AS04 vaccine in healthy female subjects up to 10 years after administration of the first vaccine dose in study HPV 014. - HPV-060 EXT 014 Y5-10For active immunization of women from the age of 10 years onwards to prevent cervical cancer (squamous-cell carcinoma and adenocarcinoma) by protecting against incident and persistent infections, cytological abnormalities including atypical squamous cells of undetermined significance (ASC US) and cervical intraepithelial neoplasia (CIN), CIN1 and pre-cancerous lesions (CIN2 and CIN3), caused by oncogenic human papillomavirus (HPV) types 16 and 18.EUCTR2009-011357-41-PLGlaxoSmithKline Biologicals667
进行中（未招募）
不适用
A Long Term Safety and Effectiveness Study of Gardasil (V501) in Preadolescents and Adolescents (V501-018)HPVMedDRA version: 18.1Level: LLTClassification code 10063001Term: Human papilloma virus infectionSystem Organ Class: 100000004862EUCTR2014-005717-23-Outside-EU/EEAMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.1,575